Han Zeng

11PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer cell biologyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 11, 2026
TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma.

|Jun 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

|Dec 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma.

Lingkai Zhang, Zhaopei Liu, Yawei Ding

|Aug 11, 2025
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.

Zhaopei Liu, Lingkai Zhang, Kaifeng Jin

Pageof 2

Frequent Collaborators

11 joint publications

Kaifeng Jin

11 joint publications

Zhaopei Liu

10 joint publications

Jiejie Xu

9 joint publications

Zewei Wang